Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15783288 | 0.98 | TDP1 (0.51) | TDP1THRBTSHRHSD17B10MEN1 | |
| SCHEMBL29519022 | 0.98 | TDP1 (0.51) | TDP1THRBTSHRHSD17B10MEN1 | |
| SCHEMBL12780621 | 0.98 | TDP1 (0.51) | TDP1THRBTSHRHSD17B10MEN1 | |
| SCHEMBL5964559 | 0.92 | THRB (0.47) | TDP1THRBTSHRMEN1KMT2A | |
| SCHEMBL5964845 | 0.92 | THRB (0.47) | TDP1THRBTSHRMEN1KMT2A | |
| SCHEMBL8851412 | 0.92 | THRB (0.47) | TDP1THRBTSHRMEN1KMT2A | |
| SCHEMBL5964715 | 0.92 | THRB (0.47) | TDP1THRBTSHRMEN1KMT2A | |
| SCHEMBL8851404 | 0.92 | THRB (0.47) | TDP1THRBTSHRMEN1KMT2A | |
| SCHEMBL8850675 | 0.92 | THRB (0.47) | TDP1THRBTSHRMEN1KMT2A | |
| SCHEMBL8851583 | 0.88 | THRB (0.50) | TDP1THRBTSHRHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9056948-B2 | Microcapsules and production thereof | FOLLMANN & CO. GESELLSCHAFT FUER CHEMIE-WERKSTOFFE UND VERFAHRENSTECHNIK MBH & CO. KG (DE) | 2015-06-16 | — | — | US | disclosed |
| US-20130137626-A1 | MICROCAPSULES AND PRODUCTION THEREOF | FOLLMANN & CO. GESELLSCHAFT FÜR CHEMIE-WERKSTOFFE UND VERFAHRENSTECHNIK MBH & CO. KG (DE) | 2013-05-30 | — | — | US | disclosed |
| US-20120122694-A1 | VERBESSERTE MICROKAPSELN UND IHRE HERSTELLUNG IMPROVED MICROCAPSULES, AND THEIR PRODUCTION THEREOF | Follmann & Co. Gesellschaft fur Chemie-Werkstoffe und Verfahrenstechnik mbH & Co. KG (DE) | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120122694-A1 | VERBESSERTE MICROKAPSELN UND IHRE HERSTELLUNG IMPROVED MICROCAPSULES, AND THEIR PRODUCTION THEREOF | VIM, ADH5, DCXR | TDP1 4851/4885THRB 3685/4885TSHR 3985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.